학술논문

Nicotine increases alcohol self-administration in male rats via a μ-opioid mechanism within the mesolimbic pathway.
Document Type
Journal Article
Source
British Journal of Pharmacology. Oct2020, Vol. 177 Issue 19, p4516-4531. 16p. 1 Diagram, 5 Graphs.
Subject
*NALTREXONE
*ALCOHOLISM
*NICOTINE
*ALCOHOL
*ALCOHOL drinking
*FENTANYL
*MENTHOL
*NUCLEUS accumbens
*NARCOTICS
*RESEARCH
*ANALGESICS
*ANIMAL experimentation
*BASAL ganglia
*RESEARCH methodology
*CELL receptors
*MEDICAL cooperation
*EVALUATION research
*RATS
*COMPARATIVE studies
*BRAIN stem
Language
ISSN
0007-1188
Abstract
Background and Purpose: Alcohol and nicotine use disorders are commonly comorbid. Both alcohol and nicotine can activate opioid systems in reward-related brain regions, leading to adaptive changes in opioid signalling upon chronic exposure. The potential role of these adaptations for comorbidity is presently unknown. Here, we examined the contribution of μ and κ-opioid receptors to nicotine-induced escalation of alcohol self-administration in rats.Experimental Approach: Chronic nicotine was tested on alcohol self-administration and motivation to obtain alcohol. We then tested the effect of the κ antagonist CERC-501 and the preferential μ receptor antagonist naltrexone on basal and nicotine-escalated alcohol self-administration. To probe μ or κ receptor adaptations, receptor binding and G-protein coupling assays were performed in reward-related brain regions. Finally, dopaminergic activity in response to alcohol was examined, using phosphorylation of DARPP-32 in nucleus accumbens as a biomarker.Key Results: Nicotine robustly induced escalation of alcohol self-administration and motivation to obtain alcohol. This was blocked by naltrexone but not by CERC-501. Escalation of alcohol self-administration was associated with decreased DAMGO-stimulated μ receptor signalling in the ventral tegmental area (VTA) and decreased pDARPP-32 in the nucleus accumbens shell in response to alcohol.Conclusions and Implications: Collectively, these results suggest that nicotine contributes to escalate alcohol self-administration through a dysregulation of μ receptor activity in the VTA. These data imply that targeting μ rather than κ receptors may be the preferred pharmacotherapeutic approach for the treatment of alcohol use disorder when nicotine use contributes to alcohol consumption. [ABSTRACT FROM AUTHOR]